Renaud Prudent - Search Results

Year	Number of Results
2007	3
2008	7
2009	3
2010	5
2011	2
2012	1
2013	3
2014	1
2015	2
2016	1
2017	1
2018	2
2019	1
2020	3
2021	3
2022	2
2023	1
2024	0

1

Prunier C, Prudent R, Kapur R, Sadoul K, Lafanechère L. Prunier C, et al. Among authors: prudent r. Oncotarget. 2017 Jun 20;8(25):41749-41763. doi: 10.18632/oncotarget.16978. Oncotarget. 2017. PMID: 28445157 Free PMC article. Review.

2

Affinity selection mass spectrometry speeding drug discovery.

Prudent R, Lemoine H, Walsh J, Roche D. Prudent R, et al. Drug Discov Today. 2023 Nov;28(11):103760. doi: 10.1016/j.drudis.2023.103760. Epub 2023 Sep 1. Drug Discov Today. 2023. PMID: 37660985 Review.

3

Exploring new targets and chemical space with affinity selection-mass spectrometry.

Prudent R, Annis DA, Dandliker PJ, Ortholand JY, Roche D. Prudent R, et al. Nat Rev Chem. 2021 Jan;5(1):62-71. doi: 10.1038/s41570-020-00229-2. Epub 2020 Oct 21. Nat Rev Chem. 2021. PMID: 37118102 Review.

4

Development of Macrocyclic PRMT5-Adaptor Protein Interaction Inhibitors.

Krzyzanowski A, Esser LM, Willaume A, Prudent R, Peter C, 't Hart P, Waldmann H. Krzyzanowski A, et al. Among authors: prudent r. J Med Chem. 2022 Nov 24;65(22):15300-15311. doi: 10.1021/acs.jmedchem.2c01273. Epub 2022 Nov 15. J Med Chem. 2022. PMID: 36378254 Free PMC article.

5

Structure-based discovery of small molecules targeting different surfaces of protein-kinase CK2.

Prudent R, Sautel CF, Cochet C. Prudent R, et al. Biochim Biophys Acta. 2010 Mar;1804(3):493-8. doi: 10.1016/j.bbapap.2009.09.003. Epub 2009 Sep 18. Biochim Biophys Acta. 2010. PMID: 19766740 Review.

6

Discovery of holoenzyme-disrupting chemicals as substrate-selective CK2 inhibitors.

Kufareva I, Bestgen B, Brear P, Prudent R, Laudet B, Moucadel V, Ettaoussi M, Sautel CF, Krimm I, Engel M, Filhol O, Borgne ML, Lomberget T, Cochet C, Abagyan R. Kufareva I, et al. Among authors: prudent r. Sci Rep. 2019 Nov 4;9(1):15893. doi: 10.1038/s41598-019-52141-5. Sci Rep. 2019. PMID: 31685885 Free PMC article.

7

New protein kinase CK2 inhibitors: jumping out of the catalytic box.

Prudent R, Cochet C. Prudent R, et al. Chem Biol. 2009 Feb 27;16(2):112-20. doi: 10.1016/j.chembiol.2009.01.004. Chem Biol. 2009. PMID: 19246001 Review.

8

[Therapeutic agents targetting protein-protein interactions: myth or reality?].

Laudet B, Prudent R, Filhol O, Cochet C. Laudet B, et al. Among authors: prudent r. Med Sci (Paris). 2007 Mar;23(3):273-8. doi: 10.1051/medsci/2007233273. Med Sci (Paris). 2007. PMID: 17349288 Free article. Review. French.

9

Novel synthetic pharmacophores inducing a stabilization of cellular microtubules.

Martinez A, Soleilhac E, Barette C, Prudent R, Gozzi GJ, Vassal-Stermann E, Pillet C, Di Pietro A, Fauvarque MO, Lafanechere L. Martinez A, et al. Among authors: prudent r. Curr Cancer Drug Targets. 2015;15(1):2-13. doi: 10.2174/1568009615666141215154149. Curr Cancer Drug Targets. 2015. PMID: 25543663

10

[Phenotypic screens or one stone to kill two birds: discover the target and its pharmacological regulator].

Prudent R, Soleilhac E, Barette C, Fauvarque MO, Lafanechère L. Prudent R, et al. Med Sci (Paris). 2013 Oct;29(10):897-905. doi: 10.1051/medsci/20132910018. Epub 2013 Oct 18. Med Sci (Paris). 2013. PMID: 24148129 Free article. Review. French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

35 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

35 results

Results by year